Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Albumin in Acute Ischemic Stroke Trial (ALIAS)

This study has been terminated.
(Recruitment halted by DSMB following interim analysis.)
Sponsor:
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
University of Calgary
Medical University of South Carolina
Neurological Emergencies Treatment Trials Network (NETT)
Information provided by (Responsible Party):
Myron Ginsberg, University of Miami
ClinicalTrials.gov Identifier:
NCT00235495
First received: September 14, 2005
Last updated: November 14, 2012
Last verified: November 2012